Psychomotor vigilance task demonstrates impaired vigilance in disorders with excessive daytime sleepiness.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 4153121)

Published in J Clin Sleep Med on September 15, 2014

Authors

Janine Thomann, Christian R Baumann, Hans-Peter Landolt, Esther Werth

Articles cited by this

A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17

The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep (2003) 9.71

Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night. Sleep (1997) 5.82

Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep (2005) 5.66

Neurocognitive consequences of sleep deprivation. Semin Neurol (2005) 5.62

Sleep deprivation and vigilant attention. Ann N Y Acad Sci (2008) 3.60

Sustained attention performance during sleep deprivation: evidence of state instability. Arch Ital Biol (2001) 3.39

Inter- and intra-individual variability in performance near the circadian nadir during sleep deprivation. J Sleep Res (2004) 2.13

Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. Sleep (2011) 2.06

Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol (2006) 1.83

Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest (1995) 1.75

Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain (2007) 1.64

Relationships between affect, vigilance, and sleepiness following sleep deprivation. J Sleep Res (2008) 1.60

Comparison of the results of the Epworth Sleepiness Scale and the Multiple Sleep Latency Test. J Psychosom Res (1997) 1.58

Circadian and wake-dependent modulation of fastest and slowest reaction times during the psychomotor vigilance task. Physiol Behav (2004) 1.43

Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Sleep Med (2003) 1.36

Gender and age differences in psychomotor vigilance performance under differential sleep pressure conditions. Behav Brain Res (2006) 1.30

Age-related changes in the time course of vigilant attention during 40 hours without sleep in men. Sleep (2006) 1.24

Reliability of a single objective measure in assessing sleepiness. Sleep (2012) 1.17

Sleep-disordered breathing and psychomotor vigilance in a community-based sample. Sleep (2007) 1.13

Time-on-task decrements in "steer clear" performance of patients with sleep apnea and narcolepsy. Sleep (1999) 1.05

Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART). Sleep (2006) 1.04

Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome. Sleep Med (2009) 1.01

Subjective sleepiness ratings (Epworth sleepiness scale) do not reflect the same parameter of sleepiness as objective sleepiness (maintenance of wakefulness test) in patients with narcolepsy. Clin Neurophysiol (1999) 0.98

Performance vigilance task and sleepiness in patients with sleep-disordered breathing. Eur Respir J (2004) 0.94

Sustained-attention capacity in young and older adults. Psychol Aging (1989) 0.94

Vigilance, arousal, and habituation. Psychol Rev (1968) 0.90

Dynamics of neurobehavioral performance variability under forced desynchrony: evidence of state instability. Sleep (2011) 0.87

Simple reaction time, duration of driving and sleep deprivation in young versus old automobile drivers. J Sleep Res (1999) 0.85

Sustained attention to response task (SART) shows impaired vigilance in a spectrum of disorders of excessive daytime sleepiness. J Sleep Res (2011) 0.83

Sleepiness and vigilance tests. Swiss Med Wkly (2009) 0.78

Articles by these authors

Sleep-disordered breathing and periodic limb movements in narcolepsy with cataplexy: a systematic analysis of 35 consecutive patients. Eur Neurol (2013) 2.05

The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med (2003) 1.72

Validation of the fatigue severity scale in a Swiss cohort. Sleep (2008) 1.72

Sleep-wake disturbances 3 years after traumatic brain injury. J Neurol Neurosurg Psychiatry (2010) 1.71

Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain (2007) 1.64

Functional ADA polymorphism increases sleep depth and reduces vigilant attention in humans. Cereb Cortex (2011) 1.29

Age-related changes in the time course of vigilant attention during 40 hours without sleep in men. Sleep (2006) 1.24

Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. Brain (2007) 1.24

Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity. J Neurosci (2006) 1.23

Functional EEG topography in sleep and waking: state-dependent and state-independent features. Neuroimage (2006) 1.14

Abnormal activity in reward brain circuits in human narcolepsy with cataplexy. Ann Neurol (2010) 1.07

Human melatonin and alerting response to blue-enriched light depend on a polymorphism in the clock gene PER3. J Clin Endocrinol Metab (2011) 1.06

The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men. J Neurosci (2009) 1.05

Increase of histaminergic tuberomammillary neurons in narcolepsy. Ann Neurol (2013) 1.04

The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity. Sleep (2012) 1.02

Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder? J Neurol (2005) 1.01

Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome. Sleep Med (2009) 1.01

Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy. Sleep (2009) 0.97

Sleep EEG changes after middle cerebral artery infarcts in mice: different effects of striatal and cortical lesions. Sleep (2006) 0.96

Sleep loss produces false memories. PLoS One (2008) 0.95

Insufficient non-REM sleep intensity in narcolepsy-cataplexy. Sleep (2007) 0.95

Challenging sleep homeostasis in narcolepsy-cataplexy: implications for non-REM and REM sleep regulation. Sleep (2008) 0.95

Interleaving deep brain stimulation for a patient with both Parkinson's disease and essential tremor. Mov Disord (2012) 0.94

Pulsed radio-frequency electromagnetic fields: dose-dependent effects on sleep, the sleep EEG and cognitive performance. J Sleep Res (2007) 0.93

REM sleep behavior disorder in Parkinson's disease: a questionnaire-based survey. J Clin Sleep Med (2013) 0.93

Random number generation during sleep deprivation: effects of caffeine on response maintenance and stereotypy. J Sleep Res (2006) 0.92

Nocturnal cerebral hemodynamics in snorers and in patients with obstructive sleep apnea: a near-infrared spectroscopy study. Sleep (2010) 0.92

Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet (2004) 0.91

Increased metabotropic glutamate receptor subtype 5 availability in human brain after one night without sleep. Biol Psychiatry (2012) 0.91

No evidence for a phase delay in human circadian rhythms after a single morning melatonin administration. J Pineal Res (2002) 0.90

Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. Sleep (2010) 0.90

Sleep deprivation increases dorsal nexus connectivity to the dorsolateral prefrontal cortex in humans. Proc Natl Acad Sci U S A (2013) 0.90

Reduced amygdala activity during aversive conditioning in human narcolepsy. Ann Neurol (2010) 0.89

Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. J Sleep Res (2010) 0.88

Alteration of internal circadian phase relationships after morning versus evening carbohydrate-rich meals in humans. J Biol Rhythms (2002) 0.87

Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans. J Neurosci (2014) 0.86

Excessive sleep need following traumatic brain injury: a case-control study of 36 patients. J Sleep Res (2013) 0.86

No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy. J Neurol (2008) 0.86

Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia. Cerebrovasc Dis (2008) 0.84

Cyclic alternating pattern in narcolepsy patients and healthy controls after partial and total sleep deprivation. Clin Neurophysiol (2011) 0.84

Sleep benefit in Parkinson's disease: time to revive an enigma? J Parkinsons Dis (2012) 0.84

Sleep inertia: performance changes after sleep, rest and active waking. Brain Res Cogn Brain Res (2004) 0.83

Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations. J Neurol (2014) 0.83

Damage to histaminergic tuberomammillary neurons and other hypothalamic neurons with traumatic brain injury. Ann Neurol (2014) 0.82

Topographic sleep EEG changes in the acute and chronic stage of hemispheric stroke. J Sleep Res (2014) 0.82

Actigraphic assessment of periodic leg movements in patients with restless legs syndrome. J Sleep Res (2013) 0.82

Asymmetric prefrontal cortex functions predict asymmetries in number space. Brain Cogn (2010) 0.82

Unusually prolonged rebound cataplexy after withdrawal of fluoxetine. Neurology (2005) 0.82

Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol (2009) 0.82

Heart rate variability in patients with idiopathic Parkinson's disease with and without obstructive sleep apnea syndrome. Parkinsonism Relat Disord (2012) 0.81

Pulsed radio frequency radiation affects cognitive performance and the waking electroencephalogram. Neuroreport (2007) 0.81

Time perception in narcolepsy in comparison to patients with Parkinson's disease and healthy controls - an exploratory study. J Sleep Res (2013) 0.81

Subthalamic deep brain stimulation versus best medical therapy for L-dopa responsive pain in Parkinson's disease. Pain (2013) 0.80

Insights into behavioral vulnerability to differential sleep pressure and circadian phase from a functional ADA polymorphism. J Biol Rhythms (2014) 0.80

Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults. Chronobiol Int (2014) 0.80

Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. Cephalalgia (2011) 0.80

Adenosine, caffeine, and performance: from cognitive neuroscience of sleep to sleep pharmacogenetics. Curr Top Behav Neurosci (2015) 0.80

Modafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep. Behav Pharmacol (2009) 0.80

Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association? Mult Scler Int (2013) 0.79

Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study. Neurology (2013) 0.79

Inter-hemispheric oscillations in human sleep. PLoS One (2012) 0.79

Parkinson's disease, sleepiness and hypocretin/orexin. Brain (2007) 0.79

Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness? J Sleep Res (2012) 0.79

Sleepwalking, REM sleep behaviour disorder and overlap parasomnia in patients with Parkinson's disease. Eur Neurol (2013) 0.78

Hypocretin-1 (orexin A) levels are normal in Huntington's disease. J Neurol (2006) 0.78

Serum cholesterol levels do not influence outcome or recovery in acute ischemic stroke. Neurol Res (2008) 0.78

CSF prostaglandin D synthase is reduced in excessive daytime sleepiness. J Neurol (2006) 0.78

Stimulation sites in the subthalamic nucleus projected onto a mean 3-D atlas of the thalamus and basal ganglia. Acta Neurochir (Wien) (2013) 0.78

CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology (2004) 0.78

Gustav Flaubert's "nervous disease": an autobiographic and epileptological approach. Epilepsy Behav (2007) 0.77

Sleep-related painful erections. Nat Clin Pract Urol (2005) 0.77

Post H1N1 vaccination narcolepsy-cataplexy with decreased CSF beta-amyloid. Sleep Med (2011) 0.77

Sleepiness at the time of testing impairs olfactory performance. Eur Neurol (2012) 0.76

Cortical morphometry in narcolepsy with cataplexy. J Sleep Res (2012) 0.76

Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment. Eur Neurol (2009) 0.75

Hypogeusia as an adverse reaction of phenytoin. Br J Clin Pharmacol (2004) 0.75

Weak with sex: sexual intercourse as a trigger for cataplexy. J Sex Med (2009) 0.75

The functions of sleep. Eur J Neurosci (2009) 0.75

Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disorders. J Perinat Med (2013) 0.75

Severe extrapyramidal syndrome after exposition to isoamyl acetate vapour. J Neurol (2008) 0.75

Post-H1N1 Flu Vaccination Narcolepsy in Switzerland: A Retrospective Survey in the 30 Sleep-Certified Swiss Centers. Eur Neurol (2016) 0.75

Sergej nikolajevich davidenkov (1880-1961). J Neurol (2011) 0.75

Hypersomnia, REM sleep fragmentation and loss of motivation in a patient with hypothalamic lesions. Sleep Med (2009) 0.75